Modulation of liver X receptor signaling as novel therapy for prostate cancer
about
Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells.Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2.Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.Loss of stearoyl-CoA desaturase activity leads to free cholesterol synthesis through increased Xbp-1 splicing.Lack of liver X receptors leads to cell proliferation in a model of mouse dorsal prostate epithelial cell.Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cellsAndrogens as therapy for androgen receptor-positive castration-resistant prostate cancer.Induction of murine embryonic stem cell differentiation by medicinal plant extractsAndrogen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.T0901317 inhibits cisplatin-induced apoptosis in ovarian cancer cells [corrected]Dentatin Induces Apoptosis in Prostate Cancer Cells via Bcl-2, Bcl-xL, Survivin Downregulation, Caspase-9, -3/7 Activation, and NF-κB Inhibition.AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1/TSC2.Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signalingPan-cancer analyses of the nuclear receptor superfamilyCholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cellsStromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout miceNegative regulation of Hedgehog signaling by liver X receptors.RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancerLiver X Receptor: Crosstalk Node for the Signaling of Lipid Metabolism, Carbohydrate Metabolism, and Innate Immunity.Orphan nuclear receptors as targets for drug development.Biological roles of liver X receptors in immune cells.LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells.Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.Effect of peripherally administered leptin antagonist on whole body metabolism and bone microarchitecture and biomechanical properties in the mouse.A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products.Expression of chicken ovalbumin upstream promoter-transcription factor II and liver X receptor as prognostic indicators for human colorectal cancerCalcitriol and TO-901317 interact in human prostate cancer LNCaP cellsCross-talk between the androgen receptor and the liver X receptor: implications for cholesterol homeostasis.Liver X receptor activation induces apoptosis of melanoma cell through caspase pathway.Dose-dependent induction of signaling pathways by the flavonoid quercetin in human primary hepatocytes: A transcriptomic study.The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis.Hedgehog signalling pathway inhibitors as cancer suppressing agents
P2860
Q33739680-D32E39A1-D0DD-46AE-AFCF-139D4588BA03Q34162761-D944C7E4-3F25-479C-A71E-7E743E0FA918Q34278855-B4349979-2C23-48FF-A116-48E9B778E121Q34287799-E6E61765-B37C-4E6A-88F1-FC5711843A41Q34425975-1D483A4A-DA5B-4D1E-B129-35F38AD808D5Q34648462-49318029-CCFF-47E1-89A9-B1F8F3109C31Q35070404-C7A50334-8278-4421-8B55-74E71884DF7FQ35207110-B387C5C6-6831-4C01-A35B-A5411516E330Q35230175-D2A93F70-2348-41DF-A03E-70B01DEE9238Q35434843-9D1F37B0-9974-4B98-B79D-51BA8C7FA8B9Q35464846-B8318B9C-CA2B-44DC-AA2E-8EFEA7E3BF6BQ36317900-63C1A645-EC53-44B1-BE20-B583A8AE9116Q36413704-94580C8C-B5E4-48DA-ABF5-7BE3C88683BDQ36790229-E105925E-AC5F-427E-85F1-820D443A7E67Q36907762-8CC4F805-01AF-48F3-8B1D-7B6A8E1F2492Q36926791-9EA87A95-2B30-4D69-A4D4-EEA8D782E8F9Q37062087-0776129A-38ED-4EEF-92E1-EB699FB5B946Q37369781-CBFDD1BA-9D57-46EA-9C03-E5B6EA149C7DQ37376541-8B6D1E1F-4F11-41FA-8359-3084952A59DEQ37597310-C105116C-BE13-4F9F-BE23-E1B5D89F09A9Q37725708-819C741F-0B80-4710-A7EF-7EC7F7713952Q38018555-4B2AEE33-3ECB-434A-AD08-AAA2CF56CF66Q38077536-5137AABE-72FB-47E3-8747-A9253886EC7DQ38699865-476BA469-D988-4833-AE06-E913D980E956Q38923071-09F60236-DD1E-43BE-8B7F-889C433EFA0EQ39133022-B6F5783F-1DDD-467E-A1D7-16301BDE8D0AQ39324576-95EC6555-9885-44A0-909B-EC458DA3F15AQ39338520-22623B5D-42C2-4273-BF2D-DF0826DDD853Q41297474-71C664F9-B634-45C6-9985-704D182406DEQ41808231-2B5F0A18-F5A1-4ABC-92B8-80D7646D520DQ41989015-516616D1-E5BE-4EE3-9670-6D7B4248A1D8Q41996704-8B362BC7-C1B8-4AAA-BBC6-8A5F6F081AE9Q52868555-BC6768AB-71C0-4EB0-992D-063794F4E66DQ54988933-9095E9BB-5163-4DFB-81A8-C564E9DB8427Q57905193-89C4F532-D14A-490A-B58F-ED4AF228CC42
P2860
Modulation of liver X receptor signaling as novel therapy for prostate cancer
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@ast
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@en
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@nl
type
label
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@ast
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@en
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@nl
prefLabel
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@ast
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@en
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@nl
P2093
P3181
P1476
Modulation of liver X receptor signaling as novel therapy for prostate cancer
@en
P2093
Chih-Pin Chuu
John M Kokontis
Richard A Hiipakka
Shutsung Liao
P2888
P304
P3181
P356
10.1007/S11373-007-9160-8
P407
P577
2007-09-01T00:00:00Z